Shijian Xiang

651 citations
37 papers · 456 indexed · h-index 13
Topics
Pharmacological Effects of Natural Compounds (7 papers)Liver Disease Diagnosis and Treatment (7 papers)Ginseng Biological Effects and Applications (6 papers)

In The Last Decade

Shijian Xiang

35 papers receiving 451 citations

Peers

Shijian Xiang
Comparison fields: 5 of 100
  • Molecular Biology 203
  • Pharmacology 99
  • Cancer Research 63
  • Epidemiology 59
  • Organic Chemistry 52
Replace Wenhui Qian with:
Wenhui Qian China
Wanisa Punfa Thailand
Jiangxue Cheng China
Sateesh Alavala India
Mi‐Young Yun South Korea
Yao-Ping Lu United States
Lucas Fernando Sérgio Gushiken Brazil
Soo‐Hyun Jung South Korea
Byung Chul Park South Korea
Rui Lai China
Shijian Xiang relative to Wenhui Qian China Wenhui Qian's profile →
Citations per field
00.5×4.5×
Wenhui Qian · 1×
Citations per year

Countries citing papers authored by Shijian Xiang

Since Specialization
Citations

This map shows the geographic impact of Shijian Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijian Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijian Xiang more than expected).

Fields of papers citing papers by Shijian Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijian Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijian Xiang. The network helps show where Shijian Xiang may publish in the future.

Co-authorship network of co-authors of Shijian Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shijian Xiang. A scholar is included among the top collaborators of Shijian Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijian Xiang. Shijian Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 4
4 0
5 4
6 8
7 7
8 17
9 11
10 43
11 15
12 24
13 21
14 40
15 7
16 22
17 12
18 46
19 18
20 1

About Shijian Xiang

Shijian Xiang is a scholar working on Pharmacology, Business and International Management and Dermatology, having authored 37 papers that have together received 456 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Ginseng Biological Effects and Applications (6 papers). The work is most often cited by research in Pharmacology (99 citations), Pharmaceutical Science (29 citations) and Dermatology (38 citations). Shijian Xiang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Huoji Chen, Benjie Zhou, Fan Xia, Hongxia Zhu, Qiang Liu, Zhuxian Wang, Wenfeng Wu, Qiang Liu, Ziqiong Liao and Zhijuan Chen. Their work appears in journals such as Biomaterials, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026